BioCryst names David Jenkins as chief scientific officer
Go back to BioCryst names David Jenkins as chief scientific officer| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.70 | 52 Week High | $10.98 | |||
| Open | $8.70 | 52 Week Low | $1.63 | |||
| Day High | $8.70 | P/E | N/A | |||
| Day Low | $8.70 | EPS | $-0.68 | |||
| Volume | 230 | |||||

